遺伝子治療用細胞培養培地の世界市場2019-2025

• 英文タイトル:Global Gene Therapy Cell Culture Media Sale, Insights Market Research Report 2019-2025

Global Gene Therapy Cell Culture Media Sale, Insights Market Research Report 2019-2025「遺伝子治療用細胞培養培地の世界市場2019-2025」(市場規模、市場予測)調査レポートです。• レポートコード:STR-DC023
• 出版社/出版日:Straits Research / 2019年11月28日
• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:バイオ技術
• 販売価格(消費税別)
  Single User(1名様用、印刷不可)¥459,000 (USD4,250)▷ お問い合わせ
  Multi User(5名様用)¥610,200 (USD5,650)▷ お問い合わせ
  Enterprise Price(法人閲覧用)¥783,000 (USD7,250)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、遺伝子治療用細胞培養培地の世界市場について調査・分析し、調査手法、市場概要、種類別(溶原培地、化学定義培地、無血清培地、特殊培地、幹細胞培地、カスタム培地、その他)分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術機関、その他)分析、地域別分析、企業概要などを含め次の構成でお届け致します。

・イントロダクション
・調査手法
・市場概要
・遺伝子治療用細胞培養培地の世界市場:種類別(溶原培地、化学定義培地、無血清培地、特殊培地、幹細胞培地、カスタム培地、その他)
・遺伝子治療用細胞培養培地の世界市場:エンドユーザー別(製薬・バイオテクノロジー企業、学術機関、その他)
・遺伝子治療用細胞培養培地の世界市場:地域別
・企業概要

Global gene therapy cell culture media market was valued at USD 142.70 million in 2018, growing at a CAGR of 10.9% during the forecast period of 2019–2026.
Gene therapy is a modern treatment for correcting defective genes. In addition, various pharmaceutical industries are focused on developing treatments for monogenic diseases. Culture media is necessary for the cell cultures to grow and survive in their incubation environment, and to support the growth and maintenance of genes. Advantages of highly concentrated feeds and media are known to pharmaceutical and biotechnology, and companies focusing on gene therapy. Concentration allows for higher cell density and improved economics in the form of lower feed rates, higher volumetric productivity, and lower volumes of media in storage, which is further improving the efficiency of the culture media for gene therapy.
Increasing research and development in gene therapy driving the growth of the market
Major players in the pharmaceutical and biotechnology sector are heavily investing in the manufacturing facilities for the development of gene therapy products. In 2019, Pfizer Inc., announced an investment of USD 500 million for expanding manufacturing facility to start experimenting on gene therapies. Additionally, in 2016, Bayer and ERS Genomics entered in Patent license agreement for Bayer to gain access to ‘ERS Genomics’ CRISPR-Cas9 patents.
Segmental Insights
For a better understanding of the global gene therapy cell culture media market, we have segmented the market by type, and end user.
By type, the market is segmented into lysogeny broth, chemically defined media, serum-free media, specialty media, stem cell media, and custom media. Chemically defined media is accounting for the second largest market share and was valued at USD 45.23 million in 2018. Chemically defined media contains amino acid in fixed proportion for cell culture and is free from any animal-derived components. Mainly, it is used in the production of vaccines and for culturing human and animal cells. In 2016, the US FDA approved cell-based flu vaccine based on cell-grown CVVs.
Regional Insights
Global gene therapy cell culture media market by Americas, Asia Pacific, Europe, and the Middle East and Africa.
North America is dominating the market and accounted for the highest share in the forecast period. Gene therapy is a booming field in North America with several approved products like ‘Luxturna’ developed by Spark Therapeutics, and ‘Zolgensma’ developed by ‘AveXis,’ to name a few. In addition, the US FDA has approved ‘Landmark AAV-Delivered Gene Therapy’ by Zolgensma to treat spinal muscular atrophy. Constant inflow of investments in research & development in gene therapy for the treatment of rare genetic diseases is likely to influence the Gene Therapy Cell Culture Media market in North America, positively. In April 2019, ‘Asklepios BioPharmaceutical (AskBio)’ bagged USD 235 million investment for the development in gene therapy
Europe is second leading region in the forecast period owing to higher healthcare spending. The growth can be attributed to increase in clinical trials for gene therapy. For instance, clinical trials increased by 37% in 2018 as compared to 2017, the Cell and Gene Therapy Catapult. In addition, several in-vivo exposure therapies are entering Phase III, which is driving the Gene Therapy Cell Culture Media media market. Moreover, Ongoing gene therapy research & development, and clinical trials are mainly sponsored by commercial and academic/non-profit sponsors. The trend for sponsorships changed upside down during 2013–2018; More than 70% of the sponsors were academic/non-profit during 2013-2015 and the number reduced to 59% and 57% in 2016 and 2017, respectively. In 2018, sponsorships from commercial entities increased to 66%, out of which only one-third were backed up by the U.K based organizations, rest were backed by companies outside the U.K.
Middle East & Africa is offering various lucrative opportunities for the market. The region homes very low number of players in gene therapy and inadequate research and development activities are restricting the growth of Gene Therapy Cell Culture Media market. However, the situation has improved a bit in the recent years as some of the major players in the pharmaceutical and biotechnology sector have started focusing on gene therapy and are looking forward to opportunities for establishing research & development centers in the Middle East & Africa.

Key Players
Some of the prominent players in the market are Lonza, HiMedia, GE Healthcare, FUJIFILM Irvine Scientific, R&D Systems, Inc. (Bio-Techne), Thermo Fisher Scientific and Sartorius AG.

レポート目次

TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Gene Therapy Cell Culture Media Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Type Overview
4.1 Introduction
4.1.1 Market Size & Forecast
4.2 Lysogeny Broth
4.3 Chemically defined media
4.4 Serum free media
4.5 Specialty media
4.6 Stem cell media
4.7 Custom media
4.8 Others
5 End User Overview
5.1 Introduction
5.1.1 Market Size & Forecast
5.2 Pharmaceutical & Biotechnology companies
5.3 Academic institutions
5.4 Research laboratories
5.5 Others
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast
6.2 America
6.2.1 North America
6.2.1.1 U.S.
6.2.1.1.1 By Type
6.2.1.1.2 By End User
6.2.1.2 Canada
6.2.1.2.1 By Type
6.2.1.2.2 By End User
6.2.1.3 Mexico
6.2.1.3.1 By Type
6.2.1.3.2 By End User
6.2.2 South America
6.2.2.1 By Type
6.2.2.2 By End User
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Western Europe
6.3.2.1 Germany
6.3.2.1.1 By Type
6.3.2.1.2 By End User
6.3.2.2 France
6.3.2.2.1 By Type
6.3.2.2.2 By End User
6.3.2.3 U.K.
6.3.2.3.1 By Type
6.3.2.3.2 By End User
6.3.2.4 Italy
6.3.2.4.1 By Type
6.3.2.4.2 By End User
6.3.2.5 Spain
6.3.2.5.1 By Type
6.3.2.5.2 By End User
6.3.2.6 Rest of Western Europe
6.3.2.6.1 By Type
6.3.2.6.2 By End User
6.3.3 Eastern Europe
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 China
6.4.2.1 By Type
6.4.2.2 By End User
6.4.3 India
6.4.3.1 By Type
6.4.3.2 By End User
6.4.4 Japan
6.4.4.1 By Type
6.4.4.2 By End User
6.4.5 South Korea
6.4.5.1 By Type
6.4.5.2 By End User
6.4.6 Australia
6.4.6.1 By Type
6.4.6.2 By End User
6.4.7 Rest of Asia-Pacific
6.4.7.1 By Type
6.4.7.2 By End User
6.5 Middle East
6.5.1 Market Size & Forecast (Value)
6.5.2 The Middle East
6.5.2.1 UAE
6.5.2.2.1 By Type
6.5.2.2.2 By End User
6.5.2.2 Qatar
6.5.2.2.1 By Type
6.5.2.2.2 By End User
6.5.2.3 Rest of Middle East
6.5.2.3.1 By Type
6.5.2.3 2 By End User
6.6 Africa
6.6.1 Market Size & Forecast (Value)
6.6.2 South Africa
6.6.2.1 South Africa
6.6.2.1.1 By Type
6.6.2.1.2 By End User
6.6.2.2 Ghana
6.6.2.2.1 By Type
6.6.2.2.2 By End User
6.6.2.3 Nigeria
6.6.2.3.1 By Type
6.6.2.3.2 By End User
6.6.2.4 Rest of Africa
6.6.2.4.1 By Type
6.6.2.4 2 By End User


7. Company Profile
7.1 Lonza
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 HiMedia
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 GE Healthcare
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 FUJIFILM Irvine Scientific
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 R&D Systems, Inc. (Bio-Techne)
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Thermo Fisher Scientific
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Sartorius AG
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio

LIST OF TABLES
TABLE 1 Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 2 Lysogeny Broth Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026 ($ Million)
TABLE 3 Chemically Defined Media Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 4 Serum Free Media Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 5 Specialty Media Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 6 Stem Cell Media Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 7 Custom Media Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 8 Others Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026, ($ Million)
TABLE 9 Gene Therapy Cell Culture Media Market Share Value, 2016-2026 ($Million)
TABLE 10 Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026 ($ Million)
TABLE 11 America Gene Therapy Cell Culture Media Market Share Value, By Region, 2016-2026 ($Million)
TABLE 12 America Gene Therapy Cell Culture Media Market Share value, By Type, 2016-2026 ($Million)
TABLE 13 America Gene Therapy Cell Culture Media Market Share value, By End User, 2016-2026 ($Million)
TABLE 14 U.S. Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 15 U.S. Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 16 Canada Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 17 Canada Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 18 Mexico Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 19 Mexico Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 20 South America Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 21 South America Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 22 Europe Gene Therapy Cell Culture Media Market Share Value, By Region, 2016-2026 ($Million)
TABLE 23 Europe Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 24 Europe Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 25 Western Europe Gene Therapy Cell Culture Media Market Share Value, By Country, 2016-2026 ($Million)
TABLE 26 Western Europe Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 27 Western Europe Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 28 Germany Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 29 Germany Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 30 France Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 31 France Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 32 UK Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 33 UK Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 34 Italy Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 35 Italy Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 36 Spain Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 37 Spain Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 38 Rest of Western Europe Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 39 Rest of Western Europe Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 40 Eastern Europe Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 41 Eastern Europe Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 42 Asia-Pacific Gene Therapy Cell Culture Media Market Share, By Country, 2016-2026 ($Million)
TABLE 43 Asia-Pacific Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 44 Asia-Pacific Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 45 Japan Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 46 Japan Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 47 China Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 48 China Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 49 Australia Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 50 Australia Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 51 India Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 52 India Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 53 South Korea Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 54 South Korea Gene Therapy Cell Culture Media Market Share, By End User 2016-2026 ($Million)
TABLE 55 Rest of Asia-pacific Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 56 Rest of Asia-pacific Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 57 The Middle East and Africa Gene Therapy Cell Culture Media Market Share, By Region, 2016-2026 ($Million)
TABLE 58 The Middle East and Africa Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 59 The Middle East and Africa Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 60 The Middle East Gene Therapy Cell Culture Media Market Share, By Country, 2016-2026 ($Million)
TABLE 61 The Middle East Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 62 The Middle East Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 63 Saudi Arabia Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 64 Saudi Arabia Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 65 UAE Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 66 UAE Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 67 Qatar Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 68 Qatar Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)
TABLE 69 Africa Gene Therapy Cell Culture Media Market Share, By Country, 2016-2026 ($Million)
TABLE 70 Africa Gene Therapy Cell Culture Media Market Share, By Type, 2016-2026 ($Million)
TABLE 71 Africa Gene Therapy Cell Culture Media Market Share, By End User, 2016-2026 ($Million)

List of Figures
FIGURE 1 Gene Therapy Cell Culture Media Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Gene Therapy Cell Culture Media Market, 2016-2026
FIGURE 9 U.S. Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 10 Canada Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 11 Mexico Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 12 South America Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 13 Western Europe Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 14 Germany Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 15 France Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 16 UK Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 17 Italy Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 18 Spain Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 19 Rest of Western Europe Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 20 Eastern Europe Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 21 Japan Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 22 China Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 23 Australia Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 24 India Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 25 South Korea Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 26 Rest of Asia-pacific Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 27 The Middle East Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 28 Saudi Arabia Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 29 UAE Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 30 Qatar Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 31 Rest of The Middle East Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 32 Africa Gene Therapy Cell Culture Media Market Share, 2016-2026 ($Million)
FIGURE 33 Lonza: Revenue Analysis, ($ million)
FIGURE 34 Lonza: Segment Revenue 2018 (%)






• 英文レポート名:Global Gene Therapy Cell Culture Media Sale, Insights Market Research Report 2019-2025
• 日本語訳:遺伝子治療用細胞培養培地の世界市場2019-2025
• レポートコード:STR-DC023お問い合わせ(見積依頼・ご注文・質問)